UK first to source coronavirus vaccines from biotech firms backed by Bill Gates

UK first to source coronavirus vaccines from biotech firms backed by Bill Gates

The Next Web

Published

The UK government revealed its stockpile of coronavirus (COVID-19) treatments on Monday, having recently secured 90 million doses of potential vaccines. Britain’s fresh agreement with Germany’s BioNTech and the Bill Gates-backed Pfizer netted 30 million doses of their joint mRNA vaccine, a first for any world government. The two companies joined forces in March to fast-track development. [Read: A look at the $17 billion stock portfolio of the Bill and Melinda Gates Foundation] French biotech company Valneva will provide 60 million doses of their “inactivated whole virus” vaccine. The UK has the option to purchase a further 40 million doses if…

This story continues at The Next Web

Full Article